# Understanding the Role of Risk Assessments for FDA Regulatory Submissions

https://accortoreg.com/news/understanding-the-role-of-risk-assessments-for-fda-regulatory-submissions-a-key-step-in-medical-device-success

> This is an informational blog post from a regulatory consulting firm (Accorto) providing practical and promotional guidance; treat it as expert-informed industry commentary useful for high-level guidance and as an example of consultant recommendations. Attribute claims to Accorto/author rather than treating them as regulatory law; verify regulatory requirements (e.g., with ISO 14971 and FDA guidance) before acting.

## Summary

The article explains why systematic risk assessments are essential for successful FDA regulatory submissions for medical devices, describes ISO 14971 as the global risk-management standard, and argues that early risk assessment and engagement with regulatory consultants can streamline development and approval. It includes a real-world example of a home peritoneal dialysis system where early risk management supported a successful 510(k) submission.

## Audience

Medical device developers and regulatory professionals

## Prompts this page answers

- Why are risk assessments important for FDA medical device submissions?
- How does ISO 14971 relate to medical device regulatory submissions?
- What are benefits of conducting early-stage risk assessments during device development?
- How can regulatory consultants help streamline a 510(k) submission?
- Can you provide an example where early risk assessment helped a medical device's regulatory approval?

## Purpose

Educate medical device developers and regulatory stakeholders about the importance of conducting early risk assessments and engaging regulatory consultants to improve safety, compliance, and the chances of successful FDA submissions.

## Highlights

- ISO 14971 is presented as the foundational global standard for medical device risk management.
- Early-stage risk assessments help identify risks in design, testing, and manufacturing and can reduce the need for additional studies later.
- Engaging regulatory consultants early can increase safety/compliance, save costs, improve product quality, and streamline submissions.
- A home peritoneal dialysis system example describes how early risk assessment and mitigation led to a successful 510(k) submission.

## How to cite

Accorto Regulatory Solutions — link: https://accortoreg.com/news/understanding-the-role-of-risk-assessments-for-fda-regulatory-submissions-a-key-step-in-medical-device-success

## Publisher

**Accorto Regulatory Solutions** — Accorto Regulatory Solutions (publisher name and contact details appear in the page footer; a regulatory services firm shown on the site).

## Topics

- risk assessment for FDA submissions
- ISO 14971
- early-stage risk assessment
- regulatory consultants
- 510(k) submission

## Key entities

- **ISO 14971** (other): International standard for medical device risk management; cited as the foundation of risk management in the article.
- **U.S. Food and Drug Administration (FDA)** (organization): Referenced as the regulatory authority for medical device submissions in the US.
- **510(k)** (other): A type of FDA premarket submission mentioned as the pathway used in the example device.
- **Home Peritoneal Dialysis System** (other): Real-world example device used in the article to illustrate early risk assessment benefits.
- **Neel Parmar** (person): Author of the article; listed as a Regulatory Writer.
- **Accorto Regulatory Solutions** (organization): Publisher of the article; contact details and address appear in the page footer. — https://accortoreg.com/

## Metadata

- Type: article
- Published: 2024-11-15